ResearcherServicio Gallego de SaludActive in the last 2 years
Rosana Simón‐Vázquez
Matched on ORCID iD 0000-0001-8963-6547; OpenAlex author ID A5085825965. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 3
2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 2 papers
Papers 4
- Harnessing epigenetic inhibitors: A promising approach for overcoming challenges in pancreatic ductal adenocarcinoma treatment. Last author DOI 10.1016/j.addr.2025.115638↗
- Sequential YAP1/FOSL1 silencing and epigenetic therapy to overcome stromal barriers in pancreatic cancer. Last author DOI 10.1016/j.ijpharm.2025.126155↗
- Immunization with nanovaccines containing mutated K-Ras peptides and imiquimod aggravates heterotopic pancreatic cancer induced in mice. Co-author DOI 10.3389/fimmu.2023.1153724↗
- Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer Cells. Last author DOI 10.3390/ph15070824↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- África González‐Fernández · 4 shared papers, 2022–2025 · strength 1.10
- Paper Harnessing epigenetic inhibitors: A promising approach for overcoming challenges in pancreatic ductal adenocarcinoma tr… DOI 10.1016/j.addr.2025.115638↗
- Paper Sequential YAP1/FOSL1 silencing and epigenetic therapy to overcome stromal barriers in pancreatic cancer. DOI 10.1016/j.ijpharm.2025.126155↗
- Paper Immunization with nanovaccines containing mutated K-Ras peptides and imiquimod aggravates heterotopic pancreatic cancer… DOI 10.3389/fimmu.2023.1153724↗
- Immacolata Maietta · 3 shared papers, 2022–2025 · strength 0.88
- Paper Harnessing epigenetic inhibitors: A promising approach for overcoming challenges in pancreatic ductal adenocarcinoma tr… DOI 10.1016/j.addr.2025.115638↗
- Paper Sequential YAP1/FOSL1 silencing and epigenetic therapy to overcome stromal barriers in pancreatic cancer. DOI 10.1016/j.ijpharm.2025.126155↗
- Paper Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer Cells. DOI 10.3390/ph15070824↗
- Amparo Martínez-Pérez · 2 shared papers, 2022–2023 · strength 0.40
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.